Cells navigating in complex microenvironments frequently encounter narrow spaces that physically challenge migration.

Kim Kelderman; Chief Executive Officer, Chief Operating Officer, Director; Bio-Techne Corp James Hippel; Chief Financial Officer, Executive Vice President - Finance; Bio-Techne Corp Good morning, and ...

Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2025. At this time, all participants have been placed in a listen-only mode and the call will ...

Jennifer Honeycutt; President and Chief Executive Officer, Director; Veralto Corp Sameer Ralhan; Chief Financial Officer and Senior Vice President; Veralto Corp My name is Margo, and I'll be your ...

Similarly, when medical device manufacturers require automated assembly systems for complex applications, they, too, turn to ...

This study provides a valuable new resource to investigate the molecular basis of the particular features characterizing the pipefish embryo. The authors found both unique and shared gene expression ...

Thomas McCarthy and David Wall from Teagasc, Johnstown Castle, Co Wexford examine the latest soil science research on ...

InDevR partners with Aldevron to describe how the VaxArray 5′CapQ assay can be used to measure intact mRNA in a single assay to streamline bioprocess development.

Type B ultrasound was used to determine the antral follicle counts (AFC). Total RNA was extracted using TRIzol Reagent (Invitrogen, CA, United States) and purified using an RNeasy Mini Kit (Qiagen, CA ...

The authors reported that, compared with the two control groups, there was no difference in direct exposures, but there was higher indirect exposure to inorganic particles, especially to metal dust, ...

Bio-Techne Corp (NASDAQ:TECH) reported stronger-than-expected earnings for the second quarter of fiscal year 2024, with adjusted earnings per share (EPS) of $0.42, surpassing the forecasted $0.39.